Literature DB >> 16424499

Fighting cancer with oncolytic viruses.

Yuti Chernajovsky1, Lorna Layward, Nicholas Lemoine.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 16424499      PMCID： PMC1336773          DOI： 10.1136/bmj.332.7534.170

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  29 in total

Review 1.  Virus proteins that counteract host immune defenses.

Authors:  L R Gooding
Journal:  Cell       Date:  1992-10-02       Impact factor: 41.582

2.  Newcastle disease virus pathotypes.

Authors:  D J Alexander; W H Allan
Journal:  Avian Pathol       Date:  1974-10       Impact factor: 3.378

3.  Expression of mouse interleukin-4 by a recombinant ectromelia virus suppresses cytolytic lymphocyte responses and overcomes genetic resistance to mousepox.

Authors:  R J Jackson; A J Ramsay; C D Christensen; S Beaton; D F Hall; I A Ramshaw
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

4.  Viral interleukin 6 stimulates human peripheral blood B cells that are unresponsive to human interleukin 6.

Authors:  E C Breen; J R Gage; B Guo; L Magpantay; M Narazaki; T Kishimoto; S Miles; O Martínez-Maza
Journal:  Cell Immunol       Date:  2001-09-15       Impact factor: 4.868

Review 5.  Cytokine receptors encoded by poxviruses: a lesson in cytokine biology.

Authors:  A Alcamí; G L Smith
Journal:  Immunol Today       Date:  1995-10

6.  Rescue of a bovine respiratory syncytial virus genomic RNA analog by bovine, human and ovine respiratory syncytial viruses confirms the "functional integrity" and "cross-recognition" of BRSV cis-acting elements by HRSV and ORSV.

Authors:  A S Yunus; S Krishnamurthy; M K Pastey; Z Huang; S K Khattar; P L Collins; S K Samal
Journal:  Arch Virol       Date:  1999       Impact factor: 2.574

7.  Vaccination with a recombinant vaccinia virus encoding a "self" antigen induces autoimmune vitiligo and tumor cell destruction in mice: requirement for CD4(+) T lymphocytes.

Authors:  W W Overwijk; D S Lee; D R Surman; K R Irvine; C E Touloukian; C C Chan; M W Carroll; B Moss; S A Rosenberg; N P Restifo
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-16       Impact factor: 11.205

8.  Phase I-II trial of ONYX-015 in combination with MAP chemotherapy in patients with advanced sarcomas.

Authors:  E Galanis; S H Okuno; A G Nascimento; B D Lewis; R A Lee; A M Oliveira; J A Sloan; P Atherton; J H Edmonson; C Erlichman; B Randlev; Q Wang; S Freeman; J Rubin
Journal:  Gene Ther       Date:  2005-03       Impact factor: 5.250

9.  Surface expression and endocytosis of the human cytomegalovirus-encoded chemokine receptor US28 is regulated by agonist-independent phosphorylation.

Authors:  Thilo Mokros; Armin Rehm; Jana Droese; Martin Oppermann; Martin Lipp; Uta E Höpken
Journal:  J Biol Chem       Date:  2002-09-18       Impact factor: 5.157

10.  Long-term human hematopoiesis in the SCID-hu mouse.

Authors:  R Namikawa; K N Weilbaecher; H Kaneshima; E J Yee; J M McCune
Journal:  J Exp Med       Date:  1990-10-01       Impact factor: 14.307
View more
  14 in total

1.  Freeze-Drying To Produce Efficacious CPMV Virus-like Particles.

Authors:  Yi Zheng; Parker W Lee; Chao Wang; Linda D Thomas; Phoebe L Stewart; Nicole F Steinmetz; Jonathan K Pokorski
Journal:  Nano Lett       Date:  2019-02-25       Impact factor: 11.189

Review 2.  Immunotherapy in urothelial cancer, part 1: T-cell checkpoint inhibition in advanced or metastatic disease.

Authors:  Steven S Yu; Tanya B Dorff; Leslie K Ballas; Sarmad Sadeghi; Eila C Skinner; David I Quinn
Journal:  Clin Adv Hematol Oncol       Date:  2017-06

3.  Oncolytic viruses in the treatment of bladder cancer.

Authors:  Kyle G Potts; Mary M Hitt; Ronald B Moore
Journal:  Adv Urol       Date:  2012-07-29

4.  Oncolytic viruses: do they have a role in anti-cancer therapy?

Authors:  Robin J Prestwich; Fiona Errington; Kevin J Harrington; Hardev S Pandha; Peter Selby; Alan Melcher
Journal:  Clin Med Oncol       Date:  2008-02-09

5.  A novel oncolytic herpes simplex virus type 2 has potent anti-tumor activity.

Authors:  Qian Zhao; Wen Zhang; Zhifeng Ning; Xiufen Zhuang; Haizhen Lu; Jing Liang; Jie Li; Yu Zhang; Ying Dong; Youhui Zhang; Shuren Zhang; Shangmei Liu; Binlei Liu
Journal:  PLoS One       Date:  2014-03-26       Impact factor: 3.240

Review 6.  Oncolytic viruses in head and neck cancer: a new ray of hope in the management protocol.

Authors:  Ps Shilpa; R Kaul; S Bhat; N Sultana; P Pandeshwar
Journal:  Ann Med Health Sci Res       Date:  2014-09

7.  Tachypleus tridentatus Lectin Enhances Oncolytic Vaccinia Virus Replication to Suppress In Vivo Hepatocellular Carcinoma Growth.

Authors:  Gongchu Li; Jianhong Cheng; Shengsheng Mei; Tao Wu; Ting Ye
Journal:  Mar Drugs       Date:  2018-06-07       Impact factor: 5.118

Review 8.  Novel delivery methods to achieve immunomodulation.

Authors:  David J Gould; Yuti Chernajovsky
Journal:  Curr Opin Pharmacol       Date:  2007-07-03       Impact factor: 5.547

9.  A comparative analysis of viral matrix proteins using disorder predictors.

Authors:  Gerard Kian-Meng Goh; A Keith Dunker; Vladimir N Uversky
Journal:  Virol J       Date:  2008-10-23       Impact factor: 4.099

Review 10.  Immune Cells in Cancer Therapy and Drug Delivery.

Authors:  Ceren Eyileten; Kinga Majchrzak; Zofia Pilch; Katarzyna Tonecka; Joanna Mucha; Bartlomiej Taciak; Katarzyna Ulewicz; Katarzyna Witt; Alberto Boffi; Magdalena Krol; Tomasz P Rygiel
Journal:  Mediators Inflamm       Date:  2016-04-24       Impact factor: 4.711
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.